Hikma Pharmaceuticals (FRA:H5P) Land And Improvements : €813 Mil (As of Dec. 2024)

View and export this data going back to . Start your Free Trial

What is Hikma Pharmaceuticals Land And Improvements?

Hikma Pharmaceuticals's land and improvements for the quarter that ended in Dec. 2024 was €813 Mil.

Hikma Pharmaceuticals's quarterly land and improvements declined from Dec. 2023 (€731 Mil) to Jun. 2024 (€0 Mil) but then increased from Jun. 2024 (€0 Mil) to Dec. 2024 (€813 Mil).

Hikma Pharmaceuticals's annual land and improvements increased from Dec. 2022 (€684 Mil) to Dec. 2023 (€731 Mil) and increased from Dec. 2023 (€731 Mil) to Dec. 2024 (€813 Mil).

Hikma Pharmaceuticals Land And Improvements Historical Data

The historical data trend for Hikma Pharmaceuticals's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hikma Pharmaceuticals Land And Improvements Chart

Hikma Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Land And Improvements

Get a 7-Day Free Trial

522.79

598.26

684.40

730.85

812.71

Hikma Pharmaceuticals Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Land And Improvements	Get a 7-Day Free Trial															684.40	-	730.85	-	812.71

Hikma Pharmaceuticals Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Hikma Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hikma Pharmaceuticals PLC (FRA:H5P) » Definitions » Land And Improvements

Comparable Companies

Traded in Other Exchanges

HKMPY:USA HKMPF:USA HIKl:UK HIK:UK

Address

1 New Burlington Place, London, GBR, W1S 2HR

Website

https://www.hikma.com

Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.

Hikma Pharmaceuticals Headlines

No Headlines